HC Wainwright upgrades Kyverna to Buy with a $5 target, citing upcoming trial data and a strong cash position that supports a runway into 2027.
With Trials In Motion, Cash To 2027, Can Kyverna’s Next Data Drop Turn The Stock Around?
Where Today's News Shapes Tomorrow
